节点文献

利凡诺去白蛋白人血浆再利用的实验研究Ⅱ.抗凝血酶Ⅲ和蛋白C抑制物的纯化与鉴定

Laboratory study on reproducibility of no albumin human plasma by rivanol precipitation Ⅱ.Purification and identification of antithrombin Ⅲ and protein C inhibitor

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张荣军; 陶永辉; 金坚; 张莲芬; 张满达; 阮长耿;

【Author】 ZHANG Rong jun 1, TAO Yong hui 1, JIN Jian 1, ZHANG Lian fen 1, ZHANG Man da 1, RUAN Chang geng 2 (1.National Laboratory of Nuclear Medicine, Wuxi 214063, China; 2.Thrombosis and Hemostasis Research Laboratory, Suzhou Medical College, Suzho

【机构】 江苏省原子医学研究所核医学国家重点实验室!江苏无锡214063; 江苏省原子医学研究所核医学国家?;

【摘要】 目的综合再利用利凡诺去白蛋白人血浆进行抗凝血成分抗凝血酶Ⅲ (AT Ⅲ )和蛋白C抑制物 (PCI)的分离纯化。方法以钡盐吸附上清为原料 ,采用铝盐吸附、有机沉淀、离子交换层析、分子筛层析、亲和层析和制备性等电聚焦等技术从利凡诺去白蛋白人血浆中分别纯化AT Ⅲ和PCI。结果从利凡诺去白蛋白人血浆 10L中得到了AT Ⅲ 16 0mg和PCI4.2mg ,得率分别为 12 .7%和 10 .5 % ,其相对分子量分别为 (5 7± 0 .8)和 (5 6± 0 .8)kD ;等电点分别为 4.81± 0 .0 2和 8.0 1± 0 .0 2 ;分别富含Glu、Asp、Leu和Glu、Leu、Asp ;毛细管区带电泳分析高度均一 ;与文献报道基本一致。结论该纯化路线经济、简便 ,有助于利凡诺去白蛋白人血浆的综合再利用和抗凝血成分输血制剂的研制和开发

【Abstract】 PurposeThe aim is to isolate and purify Antithrombin Ⅲ(AT Ⅲ) and Protein C inhibitor(PCI) from no albumin human plasma with rivanol precipitation.MethodsThe isolated and purified steps included barium adsorption, adsorption onto and elution from aluminuim, PEG precipitation, ion exchange chromatography, gel exclude chromatography, affinity chromatography, preparative isoelectric focusing and so on. Results160 mg AT Ⅲ and 4.2 mg PCI were obtained from 10 L supernatant of no albumin human plasma with rivanol precipitation. Their molecular weights are (57±0.8) and (56±0.8)kD respectively. The isoelectric point, 4.81±0.02, and 8.01±0.02; yield, 12.7% and 10.5%. The purified AT Ⅲ and PCI was shown to be highly homogeneous by capillary zone electrophoresis, and rich in Glu, Asp and Leu or Glu, Leu and Asp respectively.ConclusionThese methods were simple, cheap and efficient in improving techniques. They could be used for large scale isolation and purification from no albumin human plasma with rivanol precipitation.

【基金】 国家自然科学基金 ( 39470 2 74)
  • 【文献出处】 中国生化药物杂志 ,Chinese Journal of Biochemical Pharmaceutics , 编辑部邮箱 ,2001年04期
  • 【分类号】R965
  • 【下载频次】78
节点文献中: 

本文链接的文献网络图示:

本文的引文网络